Aptose to Present at May Investor Conferences

NEXT STORY
Hemispherx Announces Progress Toward Opening of Prostate Cancer Study at Roswell Park Comprehensive Cancer Center
PREV STORY
Rexahn Pharmaceuticals Reports First Quarter 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

NuGenerex Immuno-Oncology Announces Plans to Address the New Emerging Pandemic Threat from G4 EA H1N1 Swine Influenza Virus Using Ii-Key-H1 Peptide Vaccine

author_avatar
NASDAQ Market News

ORIC Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Update

author_avatar
NASDAQ Market News

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in electroCore, Inc. of Class Action Lawsuit and Upcoming Deadline – ECOR

author_avatar
NASDAQ Market News